Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

被引：0
|
作者：
Wen-Fei Li
Ying-Qin Li
Lei Chen
Yuan Zhang
Rui Guo
Fan Zhang
Hao Peng
Ying Sun
Jun Ma
机构：
[1] Sun Yat-sen University Cancer Center,Department of Radiation Oncology
[2] State Key Laboratory of Oncology in South China,undefined
[3] Collaborative Innovation Center for Cancer Medicine,undefined
来源：
BMC Cancer | / 15卷
关键词：
Nasopharyngeal carcinoma; Concurrent chemoradiotherapy; Induction chemotherapy; Intensity-modulated radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy
    Li, Wen-Fei
    Li, Ying-Qin
    Chen, Lei
    Zhang, Yuan
    Guo, Rui
    Zhang, Fan
    Peng, Hao
    Sun, Ying
    Ma, Jun
    BMC CANCER, 2015, 15
  • [2] Optimize the cycle of neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A propensity score matching analysis
    Peng, Hao
    Chen, Lei
    Li, Wen-Fei
    Zhang, Yuan
    Liu, Li-Zhi
    Tian, Li
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    ORAL ONCOLOGY, 2016, 62 : 78 - 84
  • [3] Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Zhai, Rui-ping
    Ying, Hong-mei
    Kong, Fang-fang
    Du, Cheng-run
    Huang, Shuang
    Zhou, Jun-jun
    Hu, Chao-su
    ONCOTARGETS AND THERAPY, 2015, 8 : 3383 - 3390
  • [4] Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
    Wee, Chan Woo
    Keam, Bhumsuk
    Heo, Dae Seog
    Sung, Myung-Whun
    Won, Tae-Bin
    Wu, Hong-Gyun
    RADIATION ONCOLOGY JOURNAL, 2015, 33 (02): : 98 - 108
  • [5] Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wu, Mingyao
    He, Xiayun
    Hu, Chaosu
    MEDICINE, 2018, 97 (50)
  • [6] Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy
    Guo, Qiaojuan
    Cui, Xiaofei
    Lin, Shaojun
    Lin, Jin
    Pan, Jianji
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E665 - E672
  • [7] Induction Chemotherapy Improved Long-term Outcomes of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Analysis of 5-year Survival Outcomes in the Era of Intensity-modulated Radiotherapy
    Peng, Hao
    Chen, Lei
    Zhang, Jian
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Yuan
    Liu, Li-Zhi
    Tian, Li
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    JOURNAL OF CANCER, 2017, 8 (03): : 371 - 377
  • [8] Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
    Wang, Fangzheng
    Sun, Quanquan
    Jiang, Chuner
    Liu, Tongxin
    Rihito, Aizawa
    Masoto, Sakamoto
    Wang, Yuezhen
    Fu, Zhenfu
    Chen, Ming
    JOURNAL OF CANCER, 2018, 9 (03): : 594 - 603
  • [9] y Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
    Wang, Fangzheng
    Jiang, Chuner
    Wang, Lai
    Yan, Fengqin
    Sun, Quanquan
    Ye, Zhimin
    Liu, Tongxin
    Fu, Zhenfu
    Jiang, Yangming
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity-modulated radiotherapy with or without concurrent chemotherapy: A propensity score-matched analysis
    Lai, YuLin
    Wang, ChengTao
    Yang, XingLi
    He, ShaSha
    Wang, Yan
    Chen, Yong
    CANCER MEDICINE, 2023, 12 (03): : 2970 - 2978
12345